+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of HBV-related liver disease in the dialysis population: reality and promises



Treatment of HBV-related liver disease in the dialysis population: reality and promises



International Journal of Artificial Organs 24(9): 598-605




(PDF emailed within 1 workday: $29.90)

Accession: 035980436

Download citation: RISBibTeXText

PMID: 11693415


Related references

Treatment of HCV-related liver disease in the dialysis population: a novel challenge for clinical nephrologists. International Journal of Artificial Organs 24(6): 335-346, 2001

Perceived aluminum-related disease in a dialysis population. A report from the End-Stage Renal Disease Network 28. Archives of Internal Medicine 149(11): 2541-2544, 1989

Hepatitis C-related liver disease in dialysis patients. Contributions to Nephrology 176: 42-53, 2012

Vitamin E as a Treatment for Nonalcoholic Fatty Liver Disease: Reality or Myth?. Antioxidants 7(1), 2018

Disappearance of aluminic bone disease in a long term asymptomatic dialysis population restricting A1(OH)3 intake: emergence of an idiopathic adynamic bone disease not related to aluminum. Nephron 53(2): 93-101, 1989

Use of dialysis in the treatment of renal failure in liver disease. Postgraduate Medical Journal 51(598): 515-520, 1975

Dialysis in the treatment of renal failure in patients with liver disease. Clinical Nephrology 8(1): 287-292, 1977

Value of dialysis in the treatment of renal failure in patients with liver disease. Digestion 14(5/6): 555, 1976

Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease. Przeglad Gastroenterologiczny 13(4): 337-339, 2018

Precipitation of dialysis dementia by deferoxamine treatment of aluminum-related bone disease. American Journal of Kidney Diseases 12(2): 126-130, 1988

Retrospective investigation of anti-VEGF treatment reality and effectiveness in patients with neovascular age-related macular degeneration (AMD) in Germany: treatment reality of ranibizumab for neovascular AMD in Germany. Der Ophthalmologe 112(3): 246-254, 2016

Hepatitis C in dialysis patients: relationship to blood transfusions, dialysis and liver disease. Kidney International 43(6): 1353-1356, 1993

Hepatitis C in dialysis patients in egypt: relationship to dialysis duration, blood transfusion, and liver disease. Saudi Journal of Kidney Diseases and Transplantation 11(1): 72-73, 2008

Influence of dialysis center ownership characteristics and dialysis to population ratios on patient selection and treatment. Kidney International 10(6): 519, 1976

Albumin-dialysis MARS Treatment of patients with acute critical decompensation of alcoholic liver disease. Hepatology 30(4 PART 2): 588A, 1999